Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial

<p>Abstract</p> <p>Background</p> <p>Hydrodilatation of the glenohumeral joint is by several authors reported to improve shoulder pain and range of motion for patients with adhesive capsulitis. Procedures described often involve the injection of corticosteroids, to whic...

Full description

Bibliographic Details
Main Authors: Juel Niels, Sesseng Sølve, Tariq Rana, Tveitå Einar, Bautz-Holter Erik
Format: Article
Language:English
Published: BMC 2008-04-01
Series:BMC Musculoskeletal Disorders
Online Access:http://www.biomedcentral.com/1471-2474/9/53
_version_ 1829495729245126656
author Juel Niels
Sesseng Sølve
Tariq Rana
Tveitå Einar
Bautz-Holter Erik
author_facet Juel Niels
Sesseng Sølve
Tariq Rana
Tveitå Einar
Bautz-Holter Erik
author_sort Juel Niels
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Hydrodilatation of the glenohumeral joint is by several authors reported to improve shoulder pain and range of motion for patients with adhesive capsulitis. Procedures described often involve the injection of corticosteroids, to which the reported treatment effects may be attributed. Any important contribution arising from the hydrodilatation procedure itself remains to be demonstrated.</p> <p>Methods</p> <p>In this randomized trial, a hydrodilatation procedure including corticosteroids was compared with the injection of corticosteroids without dilatation. Patients were given three injections with two-week intervals, and all injections were given under fluoroscopic guidance. Outcome measures were the Shoulder Pain and Disability Index (SPADI) and measures of active and passive range of motion. Seventy-six patients were included and groups were compared six weeks after treatment. The study was designed as an open trial.</p> <p>Results</p> <p>The groups showed a rather similar degree of improvement from baseline. According to a multiple regression analysis, the effect of dilatation was a mean improvement of 3 points (confidence interval: -5 to 11) on the SPADI 0–100 scale. T-tests did not demonstrate any significant between-group differences in range of motion.</p> <p>Conclusion</p> <p>This study did not identify any important treatment effects resulting from three hydrodilatations that included steroid compared with three steroid injections alone.</p> <p>Trial registration</p> <p>The study is registered in Current Controlled Trials with the registration number ISRCTN90567697.</p>
first_indexed 2024-12-16T07:17:18Z
format Article
id doaj.art-6620c967990a4e3f9dfa6235e5ada55a
institution Directory Open Access Journal
issn 1471-2474
language English
last_indexed 2024-12-16T07:17:18Z
publishDate 2008-04-01
publisher BMC
record_format Article
series BMC Musculoskeletal Disorders
spelling doaj.art-6620c967990a4e3f9dfa6235e5ada55a2022-12-21T22:39:44ZengBMCBMC Musculoskeletal Disorders1471-24742008-04-01915310.1186/1471-2474-9-53Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trialJuel NielsSesseng SølveTariq RanaTveitå EinarBautz-Holter Erik<p>Abstract</p> <p>Background</p> <p>Hydrodilatation of the glenohumeral joint is by several authors reported to improve shoulder pain and range of motion for patients with adhesive capsulitis. Procedures described often involve the injection of corticosteroids, to which the reported treatment effects may be attributed. Any important contribution arising from the hydrodilatation procedure itself remains to be demonstrated.</p> <p>Methods</p> <p>In this randomized trial, a hydrodilatation procedure including corticosteroids was compared with the injection of corticosteroids without dilatation. Patients were given three injections with two-week intervals, and all injections were given under fluoroscopic guidance. Outcome measures were the Shoulder Pain and Disability Index (SPADI) and measures of active and passive range of motion. Seventy-six patients were included and groups were compared six weeks after treatment. The study was designed as an open trial.</p> <p>Results</p> <p>The groups showed a rather similar degree of improvement from baseline. According to a multiple regression analysis, the effect of dilatation was a mean improvement of 3 points (confidence interval: -5 to 11) on the SPADI 0–100 scale. T-tests did not demonstrate any significant between-group differences in range of motion.</p> <p>Conclusion</p> <p>This study did not identify any important treatment effects resulting from three hydrodilatations that included steroid compared with three steroid injections alone.</p> <p>Trial registration</p> <p>The study is registered in Current Controlled Trials with the registration number ISRCTN90567697.</p>http://www.biomedcentral.com/1471-2474/9/53
spellingShingle Juel Niels
Sesseng Sølve
Tariq Rana
Tveitå Einar
Bautz-Holter Erik
Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial
BMC Musculoskeletal Disorders
title Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial
title_full Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial
title_fullStr Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial
title_full_unstemmed Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial
title_short Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial
title_sort hydrodilatation corticosteroids and adhesive capsulitis a randomized controlled trial
url http://www.biomedcentral.com/1471-2474/9/53
work_keys_str_mv AT juelniels hydrodilatationcorticosteroidsandadhesivecapsulitisarandomizedcontrolledtrial
AT sessengsølve hydrodilatationcorticosteroidsandadhesivecapsulitisarandomizedcontrolledtrial
AT tariqrana hydrodilatationcorticosteroidsandadhesivecapsulitisarandomizedcontrolledtrial
AT tveitaeinar hydrodilatationcorticosteroidsandadhesivecapsulitisarandomizedcontrolledtrial
AT bautzholtererik hydrodilatationcorticosteroidsandadhesivecapsulitisarandomizedcontrolledtrial